• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHZ2100609 恩格列净片 empagliflozin Tablet Chemical Drugs License Renew 2021-08-16 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG view
JYHZ2100608 恩格列净片 empagliflozin Tablet Chemical Drugs License Renew 2021-08-16 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG view
JYHZ2100607 恩格列净片 empagliflozin Tablet Chemical Drugs License Renew 2021-08-16 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG view
JYHZ2100606 恩格列净片 empagliflozin Tablet Chemical Drugs License Renew 2021-08-16 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG view
JYHZ2100605 恩格列净片 empagliflozin Tablet Chemical Drugs License Renew 2021-08-16 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG view
JYHF2000084 恩格列净片 empagliflozin Tablet Chemical Drugs Supplementary Application 2020-09-03 上海勃林格殷格翰药业有限公司 Boehringer Ingelheim Shanghai Pharmaceuticals Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG Filed 2020-09-11 view
JYHF1700104 恩格列净片 empagliflozin Tablet Chemical Drugs Supplementary Application 2017-10-23 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG Certificate Issued 2017-11-21 view
JYHF1700103 恩格列净片 empagliflozin Tablet Chemical Drugs Supplementary Application 2017-10-23 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG Certificate Issued 2017-11-21 view
JYHB2400612 恩格列净片 empagliflozin Tablet Chemical Drugs Supplementary Application 2024-11-25 Boehringer Ingelheim International GmbH;Boehringer Ingelheim Seiyaku Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG view
JYHB2400611 恩格列净片 empagliflozin Tablet Chemical Drugs Supplementary Application 2024-11-25 Boehringer Ingelheim International GmbH;Boehringer Ingelheim Seiyaku Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG view
JYHB2400610 恩格列净片 empagliflozin Tablet Chemical Drugs Supplementary Application 2024-11-25 Boehringer Ingelheim International GmbH view
JYHB2400609 恩格列净片 empagliflozin Tablet Chemical Drugs Supplementary Application 2024-11-25 Boehringer Ingelheim International GmbH;Boehringer Ingelheim Seiyaku Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG view
JYHB2400608 恩格列净片 empagliflozin Tablet Chemical Drugs Supplementary Application 2024-11-25 Boehringer Ingelheim International GmbH view
JYHB2300717 恩格列净片 empagliflozin Tablet Chemical Drugs Supplementary Application 2023-12-14 Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG view
JYHB2300716 恩格列净片 empagliflozin Tablet Chemical Drugs Supplementary Application 2023-12-14 Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG view
JYHB2300083 恩格列净片 empagliflozin Tablet Chemical Drugs Supplementary Application 2023-02-01 Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG view
JYHB2300082 恩格列净片 empagliflozin Tablet Chemical Drugs Supplementary Application 2023-02-01 Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG view
JYHB2200337 恩格列净片 empagliflozin Tablet Chemical Drugs Supplementary Application 2022-07-02 Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG view
JYHB2200336 恩格列净片 empagliflozin Tablet Chemical Drugs Supplementary Application 2022-07-02 Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG view
JYHB2200214 恩格列净片 empagliflozin Tablet Chemical Drugs Supplementary Application 2022-04-15 Boehringer Ingelheim International GmbH;Boehringer Ingelheim Seiyaku Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG view